ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DAVID EASTERDAY D.O.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,330Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 1499

$914K Total Retail Price of All Prescriptions

Rank: 88 out of 1499

565 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 10,763 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 628 413 1 3
LISINOPRIL 486 309 2 1
HYDROCODONE-ACETAMINOPHEN 474 317 S3 3 4
FUROSEMIDE 437 356 4 7
LEVOTHYROXINE SODIUM 436 338 5 2
AMLODIPINE BESYLATE 395 360 6 6
RANITIDINE HCL 361 200 7 15
METFORMIN HCL 350 205 8 8
CITALOPRAM HBR 342 251 9 14
OMEPRAZOLE 328 199 10 5
GABAPENTIN 312 179 11 13
WARFARIN SODIUM 235 175 12 12
HYDROCHLOROTHIAZIDE 233 160 13 9
NAMENDA 214 201 14 47
POTASSIUM CHLORIDE 214 176 14 11
METOPROLOL TARTRATE 206 129 16 10
CARVEDILOL 205 192 17 22
DONEPEZIL HCL 201 185 18 35
LOVASTATIN 193 153 19 19
ATORVASTATIN CALCIUM 173 110 20 17
PANTOPRAZOLE SODIUM 171 119 21 48
CLOPIDOGREL 167 136 22 39
ALENDRONATE SODIUM 165 130 23 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 116 24 25
GLIMEPIRIDE 143 125 25 38
CRESTOR 134 74 26 34
TRAMADOL HCL 129 67 27 16
PROAIR HFA 129 42 27 30
ATENOLOL 128 116 29 21
TAMSULOSIN HCL 124 75 30 29
POLYETHYLENE GLYCOL 3350 121 80 31 52
GLIPIZIDE 120 88 32 64
PRAVASTATIN SODIUM 117 103 33 18
LANTUS 115 86 34 46
FENTANYL 103 69 S2 35 60
PLAVIX 99 80 36 54
CYCLOBENZAPRINE HCL 98 31 R 37 41
SERTRALINE HCL 97 71 38 24
ZOLPIDEM TARTRATE 95 68 39 23
FLUTICASONE PROPIONATE 95 61 39 31
TRAZODONE HCL 95 36 39 32
ADVAIR DISKUS 91 64 42 37
ESCITALOPRAM OXALATE 90 71 43 76
MIRTAZAPINE 90 84 43 50
DIGOXIN 89 79 45 56
LOSARTAN POTASSIUM 84 72 46 26
FAMOTIDINE 84 53 46 86
METOPROLOL SUCCINATE 79 67 48 20
PREDNISONE 76 67 49 42
QUINAPRIL HCL 74 64 50 125
PAROXETINE HCL 74 54 50 59
SPIRIVA 74 52 50 44
RISPERIDONE 73 40 53 74
AMLODIPINE BESYLATE-BENAZEPRIL 71 44 54 109
ISOSORBIDE MONONITRATE ER 69 69 55 51
SYMBICORT 68 27 56 121
CELEBREX 68 50 56 77
JANUVIA 67 47 58 84
NEXIUM 65 35 59 28
DIOVAN 65 54 59 58
AMITRIPTYLINE HCL 64 33 R 61 49
AZITHROMYCIN 64 39 61 45
OXYBUTYNIN CHLORIDE ER 63 49 63 141
OXYCODONE-ACETAMINOPHEN 63 30 S2 63 80
CARBIDOPA-LEVODOPA 62 61 65 92
TRIAMTERENE-HCTZ 62 53 65 62
FLUOXETINE HCL 62 22 65 43
LEVOFLOXACIN 60 43 68 101
ALLOPURINOL 60 42 68 36
CIPROFLOXACIN HCL 58 48 70 65
CLONIDINE HCL 53 46 71 57
DILTIAZEM ER 52 52 72 124
OXYBUTYNIN CHLORIDE 50 24 73 95
EXELON 50 40 73 166
QUETIAPINE FUMARATE 50 28 73 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.